uk
uk · page 2
- Interviews
Ireland’s Dunbar Pharma Launches First Plant-Derived Dronabinol in UK Through IPS Pharma
Irish pharmaceutical cannabis manufacturer Dunbar Pharmaceuticals has today launched the first plant-derived dronabinol active ingredient into the UK market.
- Medical Cannabis
UK Medical Cannabis Prescriptions Hit 1.7 Million in 2025 as ACMD Review Approaches
More than a year has passed since the Advisory Council on the Misuse of Drugs (ACMD) was commissioned to conduct a formal review of the UK’s medical cannabis industry.
- Opinion
Selling US Grown Flower to Europe: What the Margin Actually Says
Written by Michael Sassano, Founder and Interim CEO, SOMAÍ Pharmaceuticals Most US cannabis companies thinking about Europe focus on the wrong number.
- Prescribers & Clinics
The Human Side of Hypergrowth: Recruitment, Culture and Maintaining Standards at Releaf
The UK has another new Prime Minister, Andy Burnham, who has wasted no time in laying out his plans to fundamentally reform the country’s creaking healthcare infrastructure.
- Opinion
Opinion: New Labour Administration Can End Britain’s Failed Cannabis Experiment
Written by Omar Khan, Chief Communications and Public Affairs Officer, High Tide Inc.
- Opinion
Patients First: What Training the Police Taught Me About Medical Cannabis
As new national guidance instructs officers to treat medical cannabis users as patients first, James Duckenfield, CEO of Glass Pharms, reflects on what training police forces has taught him about the gap between the law and the general understanding of the legal landscape, and how the industry as a whole can help close it.
- Medical Cannabis
Measuring What Matters: Why Outcomes Will Decide the Future of Cannabis Medicine
The UK medical cannabis sector has spent seven years arguing for access.
- Cultivation
Rua Bioscience Signs its Largest-Ever Export Deal With Unnamed UK Cannabis Clinic
New Zealand-listed Rua Bioscience (NZX: RUA) has agreed a sales and distribution deal with one of the UK’s largest medicinal cannabis clinic and distribution businesses, expected to generate NZ$10m in revenue over two years, the company’s largest export contract to date.
- Medical Cannabis
Who Really Benefits from Britain’s Medical Cannabis System?
Written for Business of Cannabis by Saxon Coop, Founder & CEO of Toke.
- Prescribers & Clinics
Nine of the Ten Top CBPM Prescribers Are Pharmacists, FOI Data Shows
New data acquired by Business of Cannabis has, for the first time, shed light on the professional types behind England’s CBPM prescribing record, raising further questions about assertions that ‘10 doctors prescribe half of the UK’s medical cannabis’.
- Prescribers & Clinics
Curaleaf International Launches CPD-Accredited Education Platform for UK Cannabis Prescribers
Curaleaf International has launched a free CPD-accredited online education platform for UK healthcare professionals to help close the training gap the country’s professional medical community continues to face.
- Medical Cannabis
Curaleaf Laboratories and Herdade das Barrocas (HDB) Announce Strategic Partnership to Reintroduce HDB Products to the UK Medical Cannabis Market
Curaleaf Laboratories, one of the UK’s leading manufacturers and distributors of EU-GMP medical cannabis products and Herdade das Barrocas (HDB), a Portuguese cultivator known for its cannabis genetics and cultivation expertise, are pleased to announce a new manufacturing and supply partnership that will see HDB products reintroduced to healthcare professionals and patients across the United…
